NEWBRY logo

Newbury Pharmaceuticals AB (publ) Stock Price

OM:NEWBRY Community·SEK 42.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

NEWBRY Share Price Performance

SEK 1.41
-1.22 (-46.37%)
SEK 1.41
-1.22 (-46.37%)
Price SEK 1.41

NEWBRY Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with adequate balance sheet.

5 Risks
0 Rewards

Newbury Pharmaceuticals AB (publ) Key Details

SEK 32.8m

Revenue

SEK 24.1m

Cost of Revenue

SEK 8.7m

Gross Profit

SEK 37.2m

Other Expenses

-SEK 28.5m

Earnings

Last Reported Earnings
Feb 28, 2026
Next Reporting Earnings
Jul 08, 2026
-0.94
26.47%
-86.90%
0%
View Full Analysis

About NEWBRY

Founded
2020
Employees
7
CEO
Karl Alexius Tiger Karlsson
WebsiteView website
www.newburypharma.com

Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden and the Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. Newbury Pharmaceuticals AB (publ) was incorporated in 2020 and is based in Lund, Sweden.

Recent NEWBRY News & Updates

Recent updates

No updates